170 related articles for article (PubMed ID: 24178904)
1. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
[TBL] [Abstract][Full Text] [Related]
2. Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.
Lee J; Seo JW; Jun HJ; Ki CS; Park SH; Park YS; Lim HY; Choi MG; Bae JM; Sohn TS; Noh JH; Kim S; Jang HL; Kim JY; Kim KM; Kang WK; Park JO
Oncol Rep; 2011 Jun; 25(6):1517-24. PubMed ID: 21424128
[TBL] [Abstract][Full Text] [Related]
3. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
5. Gene amplification of ribosomal protein S6 kinase-1 and -2 in gastric cancer.
Yoshida S; Matsumoto K; Arao T; Taniguchi H; Goto I; Hanafusa T; Nishio K; Yamada Y
Anticancer Res; 2013 Feb; 33(2):469-75. PubMed ID: 23393338
[TBL] [Abstract][Full Text] [Related]
6. Detection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization.
Kiyose S; Nagura K; Tao H; Igarashi H; Yamada H; Goto M; Maeda M; Kurabe N; Suzuki M; Tsuboi M; Kahyo T; Shinmura K; Hattori N; Sugimura H
Pathol Int; 2012 Jul; 62(7):477-84. PubMed ID: 22691185
[TBL] [Abstract][Full Text] [Related]
7. Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer.
Nam KH; Lee BL; Park JH; Kim J; Han N; Lee HE; Kim MA; Lee HS; Kim WH
Pathobiology; 2013; 80(2):87-94. PubMed ID: 23038627
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma.
Jung EJ; Jung EJ; Min SY; Kim MA; Kim WH
Hum Pathol; 2012 Oct; 43(10):1559-66. PubMed ID: 22440694
[TBL] [Abstract][Full Text] [Related]
10. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
[TBL] [Abstract][Full Text] [Related]
11. Identification of protein expression signatures in gastric carcinomas using clustering analysis.
Begnami MD; Fregnani JH; Brentani H; Torres C; Costa WL; Montagnini A; Nonogaki S; Soares FA
J Gastroenterol Hepatol; 2012 Feb; 27(2):378-84. PubMed ID: 21777278
[TBL] [Abstract][Full Text] [Related]
12. Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer.
Park JH; Lee BL; Yoon J; Kim J; Kim MA; Yang HK; Kim WH
Hum Pathol; 2010 Dec; 41(12):1664-73. PubMed ID: 20869748
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of MUTYH with suppressive activity against mutations caused by 8-hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer.
Shinmura K; Goto M; Suzuki M; Tao H; Yamada H; Igarashi H; Matsuura S; Maeda M; Konno H; Matsuda T; Sugimura H
J Pathol; 2011 Nov; 225(3):414-23. PubMed ID: 21826668
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab combined with docetaxel-based regimens in previously treated metastatic gastric cancer patients with HER2 over-expression.
Dai GH; Shi Y; Chen L; Lv YL; Zhong M
Hepatogastroenterology; 2012; 59(120):2439-44. PubMed ID: 22534547
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival.
Xu L; Li X; Chu ES; Zhao G; Go MY; Tao Q; Jin H; Zeng Z; Sung JJ; Yu J
Gut; 2012 Jul; 61(7):977-85. PubMed ID: 21917650
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
Park YS; Hwang HS; Park HJ; Ryu MH; Chang HM; Yook JH; Kim BS; Jang SJ; Kang YK
Hum Pathol; 2012 Mar; 43(3):413-22. PubMed ID: 21855114
[TBL] [Abstract][Full Text] [Related]
19. Formyl Peptide receptor 1 expression is associated with tumor progression and survival in gastric cancer.
Cheng TY; Wu MS; Lin JT; Lin MT; Shun CT; Hua KT; Kuo ML
Anticancer Res; 2014 May; 34(5):2223-9. PubMed ID: 24778024
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
